版本:
中国

BRIEF-Collplant Holdings reports positive results from post-marketing surveillance of Vergenix FG

April 11 Collplant Holdings Ltd:

* Announce positive results from post-marketing surveillance of company's advanced wound care product, Vergenix FG

* As part of surveillance, co monitored 10 patients following a single treatment with Vergenix FG in hospitals in Italy, Switzerland

* Study showed 5 weeks post treatment, patients displayed average wound closure rate of 80%, with no observed safety/ tolerability issues Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐